- Home
- DRMA vs ATNF Comparison
DRMA vs ATNF Comparison
Compare DRMA & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRMA
- ATNF
- Stock Information
- Founded
- DRMA 2014
- ATNF 2016
- Country
- DRMA United States
- ATNF United States
- Employees
- DRMA N/A
- ATNF N/A
- Industry
- DRMA Biotechnology: Pharmaceutical Preparations
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- DRMA Health Care
- ATNF Health Care
- Exchange
- DRMA Nasdaq
- ATNF Nasdaq
- Market Cap
- DRMA 4.5M
- ATNF 3.8M
- IPO Year
- DRMA 2021
- ATNF N/A
- Fundamental
- Price
- DRMA $0.75
- ATNF $1.05
- Analyst Decision
- DRMA Strong Buy
- ATNF
- Analyst Count
- DRMA 1
- ATNF 0
- Target Price
- DRMA $3.00
- ATNF N/A
- AVG Volume (30 Days)
- DRMA 70.9K
- ATNF 42.9K
- Earning Date
- DRMA 05-14-2025
- ATNF 05-15-2025
- Dividend Yield
- DRMA N/A
- ATNF N/A
- EPS Growth
- DRMA N/A
- ATNF N/A
- EPS
- DRMA N/A
- ATNF N/A
- Revenue
- DRMA N/A
- ATNF N/A
- Revenue This Year
- DRMA N/A
- ATNF N/A
- Revenue Next Year
- DRMA N/A
- ATNF N/A
- P/E Ratio
- DRMA N/A
- ATNF N/A
- Revenue Growth
- DRMA N/A
- ATNF N/A
- 52 Week Low
- DRMA $0.66
- ATNF $0.66
- 52 Week High
- DRMA $5.00
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- DRMA 44.67
- ATNF 49.77
- Support Level
- DRMA $0.66
- ATNF $1.01
- Resistance Level
- DRMA $0.75
- ATNF $1.10
- Average True Range (ATR)
- DRMA 0.05
- ATNF 0.08
- MACD
- DRMA 0.00
- ATNF -0.01
- Stochastic Oscillator
- DRMA 44.50
- ATNF 35.29
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.